NKG2A/C/E Antibodies
(Killer Cell Lectin-Like Receptor Subfamily C, Member 1/2/3 (KLRC1/2/3))
antibodies-online.com stands for high-quality research products. Search, find and order tools with extensive validation data, images, references. Our scientific customer service is always at your disposal if you have any questions about the selection or application of our products.
Recommended NKG2A/C/E Antibodies
Product
Reactivity
Application
Validations
Cat. No.
Quantity
Datasheet
Reactivity
Mouse
Application
FACS
Validations
- (1)
Cat. No.
ABIN135339
Quantity
0.1 mg
Datasheet
Datasheet
Reactivity
Mouse
Application
FACS
Validations
- (1)
Cat. No.
ABIN135336
Quantity
0.5 mg
Datasheet
Datasheet
Reactivity
Mouse
Application
FACS
Validations
- (1)
Cat. No.
ABIN135338
Quantity
0.5 mg
Datasheet
Datasheet
Latest Publications for our NKG2A/C/E products
: "Viral and bacterial infections induce expression of multiple NK cell receptors in responding CD8(+) T cells." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 169, Issue 3, pp. 1444-52, (2002) (PubMed).: "Implications of CD94 deficiency and monoallelic NKG2A expression for natural killer cell development and repertoire formation." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 99, Issue 2, pp. 868-73, (2002) (PubMed).
: "Diversity of NK cell receptor repertoire in adult and neonatal mice." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 163, Issue 1, pp. 212-6, (1999) (PubMed).
: "Cloning of murine NKG2A, B and C: second family of C-type lectin receptors on murine NK cells." in: European journal of immunology, Vol. 29, Issue 3, pp. 755-61, (1999) (PubMed).
: "Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b)." in: The Journal of experimental medicine, Vol. 188, Issue 10, pp. 1841-8, (1999) (PubMed).
: "Natural killer cell receptors." in: Current opinion in immunology, Vol. 10, Issue 3, pp. 298-305, (1998) (PubMed).
Did you look for something else?
You are here:
